Tamura Y - Search Results

1

Predictors of hypoxemia in type-B acute aortic syndrome: a retrospective study.

Tamura Y, Tamura Y, Kametani M, Minami Y, Nakayama T, Takagi D, Unoki T, Yamamuro M, Kawamura A, Sakamoto T, Sawamura T. Tamura Y, et al. Sci Rep. 2021 Dec 3;11(1):23413. doi: 10.1038/s41598-021-02886-9. Sci Rep. 2021. PMID: 34862435 Free PMC article.

2

Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension.

Furukawa A, Tamura Y, Iwahori H, Goto M, Ohashi N, Okabe T, Kawamura A. Furukawa A, et al. Among authors: tamura y. BMC Pulm Med. 2017 Oct 26;17(1):135. doi: 10.1186/s12890-017-0480-9. BMC Pulm Med. 2017. PMID: 29073911 Free PMC article.

3

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　- A Report From a Referral Center in Japan.

Tamura Y, Takeyasu R, Furukawa A, Takada H, Takechi M, Taniguchi H, Kawamura A. Tamura Y, et al. Circ Rep. 2020 Aug 27;2(9):526-530. doi: 10.1253/circrep.CR-20-0088. Circ Rep. 2020. PMID: 33693278 Free PMC article.

4

Explainable Artificial Intelligence Model for Diagnosis of Atrial Fibrillation Using Holter Electrocardiogram Waveforms.

Taniguchi H, Takata T, Takechi M, Furukawa A, Iwasawa J, Kawamura A, Taniguchi T, Tamura Y. Taniguchi H, et al. Among authors: tamura y. Int Heart J. 2021;62(3):534-539. doi: 10.1536/ihj.21-094. Int Heart J. 2021. PMID: 34053998 Free article.

5

Pulmonary hypertension associated with neurofibromatosis type 2.

Taniguchi H, Takashima T, Tu L, Thuillet R, Furukawa A, Furukawa Y, Kawamura A, Humbert M, Guignabert C, Tamura Y. Taniguchi H, et al. Among authors: tamura y. Pulm Circ. 2021 Jul 5;11(3):20458940211029550. doi: 10.1177/20458940211029550. eCollection 2021 Jul-Sep. Pulm Circ. 2021. PMID: 34285798 Free PMC article.

6

Comparison of left ventricular pacing performance among pre-shaped guidewires designed for transfemoral-approach transcatheter aortic valve implantation.

Tamura Y, Tamura Y, Konami Y, Suzuyama H, Horio E, Yamada M, Sassa T, Taguchi E, Horibata Y, Ideta I, Kawamura A, Sakamoto T. Tamura Y, et al. Heart Vessels. 2022 Mar;37(3):460-466. doi: 10.1007/s00380-021-01938-4. Epub 2021 Sep 15. Heart Vessels. 2022. PMID: 34524498

7

Case Report: BMPR2-Targeted MinION Sequencing as a Tool for Genetic Analysis in Patients With Pulmonary Arterial Hypertension.

Takashima T, Brisset S, Furukawa A, Taniguchi H, Takeyasu R, Kawamura A, Tamura Y. Takashima T, et al. Among authors: tamura y. Front Cardiovasc Med. 2021 Sep 13;8:711694. doi: 10.3389/fcvm.2021.711694. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34589526 Free PMC article.

8

Liver fibrosis index as a novel prognostic factor in patients with pulmonary arterial hypertension.

Furukawa A, Tamura Y, Yamada K, Taniguchi H, Ohashi N, Okabe T, Kawamura A. Furukawa A, et al. Among authors: tamura y. Heart Vessels. 2022 Apr;37(4):601-608. doi: 10.1007/s00380-021-01951-7. Epub 2021 Oct 7. Heart Vessels. 2022. PMID: 34618189

9

Dasatinib-induced Pulmonary Hypertension.

Tamura Y, Tamura Y. Tamura Y, et al. Intern Med. 2022 Aug 1;61(15):2245-2246. doi: 10.2169/internalmedicine.9107-21. Epub 2022 Feb 1. Intern Med. 2022. PMID: 35110497 Free PMC article. No abstract available.

10

Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension.

Tamura Y, Furukawa A, Tamura Y, Yamada K, Taniguchi H, Fukuda K, Kawamura A, Satoh T. Tamura Y, et al. Pulm Circ. 2022 Mar 17;12(1):e12058. doi: 10.1002/pul2.12058. eCollection 2022 Jan. Pulm Circ. 2022. PMID: 35506073 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,825 results

Search Page

Filters